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Background: Earlier research showed that healthcare in stroke could be better organized, aiming for improved
survival and less comorbidity. Therefore, in 2004 the Dutch College of General Practitioners (NHG) and the Dutch
Association of Neurology (NVN) introduced the ‘Dutch Transmural Protocol TIA/CVA’ (the LTA) to improve survival,
minimize the risk of stroke recurrence, and increase quality of life after stroke. This study examines whether survival
improved after implementation of the new protocol, and whether there was an increase in contacts with the
general practitioner (GP)/nurse practitioner, registration of comorbidity and prescription of medication.
Methods: From the primary care database of the Registration Network Groningen (RNG) two cohorts were composed:
one cohort compiled before and one after introduction of the LTA. Cohort 1 (n = 131, first stroke 2001–2002) was
compared with cohort 2 (n = 132, first stroke 2005–2006) with regard to survival and the secondary outcomes.
Results: Comparison of the two cohorts showed no significant improvement in survival. In cohort 2, the number of
contacts with the GP was significantly lower and with the nurse practitioner significantly higher, compared with cohort
1. All risk factors for stroke were more prevalent in cohort 2, but were only significant for hypercholesterolemia. In both
cohorts more medication was prescribed after stroke, whereas ACE inhibitors were prescribed more frequently only in
cohort 2.
Conclusion: No major changes in survival and secondary outcomes were apparent after introduction of the LTA.
Although, there was a small improvement in secondary prevention, this study shows that optimal treatment after
introduction of the LTA has not yet been achieved.
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The prevalence of stroke in general practice in the
Netherlands is 13.3 in 1000 men and 13.4 in 1000
women [1]. Additionally, within 5 years after stroke, 50%
of patients will die and 30-50% will experience another
stroke [2].
A stroke has considerable impact on the patient’s life
and his/her family [2,3]. Stroke can cause various
neurological deficits, including paralysis, loss of vision,
aphasia, spatial disorder, disturbance in thinking, difficulty
in swallowing and incontinence [4]. Moreover, stroke has
cognitive, behavioral, emotional and social consequences
[5] and, in the chronic phase, negatively affects quality of
life [3,4].* Correspondence: l.de.weerd@umcg.nl
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reproduction in any medium, provided the orStudies have shown that healthcare in stroke patients
could be better organized, that more thrombolysis
treatment should be given and that more admissions
to a stroke unit would result in better survival and less
comorbidity [6-9]. It became increasingly obvious that
secondary prevention (e.g. controlling blood pressure,
cholesterol and glucose) is also very important. Treatment
of cardiovascular/cerebrovascular risk factors reduces the
risk of stroke, in particular hypertensive treatment.
Moreover, consistent measurements to control whether
treatment is effective are essential in stroke prevention
programs [10]. All these findings emphasized that specific
treatment is required for stroke patients.
A transmural stroke service, in which neurologists and
general practitioners (GPs) participate, would allow
proper care to be delivered in the appropriate setting.
Patients should be quickly referred to the hospital andral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[11]. To improve survival after stroke and minimize the
risk of stroke recurrence, the Dutch College of General
Practitioners (NHG) and the Dutch Association of
Neurology (NVN) introduced the ‘Dutch Transmural
Protocol TIA/CVA’ (the LTA) in 2004 [12]. It also offers
the GP and neurologist the advice to provide quality
healthcare at the right time, without compromising the
continuity of care.
The LTA protocol states that when acute neurological
symptoms are apparent, the GP should visit the patient
immediately so that thrombolytic treatment can be
given within 3 hours after the symptoms started. Other
indications for an emergency visit are unconsciousness,
worsening of neurological symptoms, or when the event
is so worrying for the patient or his/her environment
that delay is not justified. Visiting the patient at home
can be postponed if the situation is stable and no
thrombolysis is possible [12].
The protocol recommends that agreements should be
made about healthcare between the local hospital and
GPs. In general, when a GP suspects an ischemic stroke,
treatment with a platelet inhibitor or a coumarin
derivative is started the same day and patients are
admitted to a hospital (preferably a stroke unit). The
protocol states that the neurologist is responsible for
the remaining necessary medication, and for starting




- Men 72 (55)
- Women 59 (45)
Age, in years: average [range] 69.82 [
Risk factors present before stroke/History
- K85 (high blood pressure without hypertension) 8 (6)
- K86/87 (hypertension) 34 (26)
- T93 (hypercholesterolemia) 2 (2)
- T90 (diabetes) 17 (13)
- K91 (arteriosclerosis) 2 (2)
- K89 (TIA) 5 (4)
Average number of contacts (consults and visits) with general practice in the
- Contact moments GP 5.40
- Consult GP 3.48
- Visits GP 2.46
- Contacts nurse practitioner 1.00
Average exposure time§ in days 528
*Pearson’s Chi-square test, †Independent T-test, ‡ Mann–Whitney test. §Exposure tim
the study.After discharge from hospital, the GP continues this
treatment.
Antihypertensive medication is prescribed to patients
with hypertension 2 weeks after the patient has stabilized.
The protocol advises the prescription of statins to patients
with a total cholesterol of 3.5 mmol/L or higher [12]. For
treatment of high glucose levels, the NHG protocol
‘Diabetes mellitus type 2’ must be followed [13]. Health
education should be performed by a neurologist, but the
GP should also discuss risk factors, lifestyle changes and
use of medication with the patient. This is important
because patients regard the GP and neurologist as their
main source of information [12,14,15].
GPs are responsible for assisting in the coordination of
rehabilitation and post-hospital care of patients at home.
The neurologist has to provide a discharge letter with
treatment advice and a risk profile within 1 week after
discharge from hospital to ensure that quality aftercare
is possible [12,15].
The purpose of this study is to compare the survival
of patients one year after stroke before and after the
introduction of the LTA. We were not interested in
establishing a causal relationship in survival before and
after stroke due to the introduction of LTA, but only to
show changes in survival occurring between pre- and
post LTA time periods. We expected survival to be better in
stroke patients after the introduction of the LTA, because

















e: time during which patients were registered in a general practice during
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Secondary outcomes include survival at 2-year follow-up,
difference in the number of contacts with the GP/nurse
practitioner, and difference in secondary prevention
(e.g. prescription of medication, comorbidity, risk factors).
We expected the number of contacts with the GP and the
prescription of medication and comorbidities to be higher,
because the LTA recommends that GPs check and monitor
patients more regularly after stroke.Figure 1 Survival at one-year follow-up.Methods
Study design and setting
In this registry study, the database of the Registration
Network Groningen (RNG) was used. This primary
care-based network was established in 1989, and consists
of three group practices in the northern part of the
Netherlands with about 20 GPs and about 30,000 patients
[16]. The RNG is a validated register [17]. All contacts,
diagnoses, referrals and prescriptions are registered in the
RNG using the International Classification of Primary
Care (ICPC) [18]. Anonymous patient data were used
according to the privacy assignments by the RNG. The
study was in agreement with the regulations for publication
of patient data and, therefore, no further approval was
required from the Medical Ethical Committees of the
University Medical Centre Groningen.Participants and data collection
The study includes two cohorts of patients, one cohort
compiled before and one after introduction of the LTA.
Inclusion criteria were patients who had a first stroke in
2000–2001 (cohort 1) and in 2005–2006 (cohort 2). These
patients had to be registered in the general practice for at
least one year and were followed for two years after stroke.
No additional selection criteria were applied. A total of
263 patients were included. Details on history, risk factors,
mortality, morbidity, medication and referrals were obtained
from the RNG.Figure 2 Survival at two-year follow-up.Statistical analysis
For statistical analysis SPSS 15 for Windows (SPSS Inc.,
Chicago) was used. Statistical significance was set at
p < 0.05 (two-sided). To test differences between groups
the Student’s t-test was used for normal distributed
(continuous) variables and the Mann–Whitney U test
was used for not normal distributed continuous, ordinal
scaled or count variables. The Chi-square test was used
for independent observations of nominal or dichotomous
variables. The Kaplan-Meier method was used to estimate
the survival distributions and the log-rank test was
used to compare differences in survival between the
groups [19,20].Results
Baseline characteristics
A total of 263 patients were included: 131 patients in cohort
1 (first stroke 2000–2001) and 132 patients in cohort 2
(first stroke 2005–2006). Table 1 provides details on
baseline characteristics: there were no significant differences
between the two groups.Survival
Both cohorts were followed for two years, during which
time some patients died. There was no significant
Table 2 Number (%) of deceased patients during the
two-year follow-up
Deceased Cohort 1 (%) Cohort 2 (%) p-value#
Men
- related to stroke* 8 (11) 6 (10) 0.862
- within one year 17 (24) 14 (24) 0.987
- within two years 24 (33) 18 (31) 0.730
Women
- related to stroke* 6 (10) 6 (8) 0.698
- within one year 20 (34) 18 (25) 0.244
- within two years 25 (42) 20 (27) 0.071
0-60 years
- related to stroke* 4 (3) 2 (2) 0.523
- within one year 4 (3) 2 (2) 0.523
- within two years 5 (4) 3 (2) 0.619
0-80 years
- related to stroke* 10 (8) 6 (5) 0.306
- within one year 21 (16) 15 (11) 0.280
- within two years 27 (21) 17 (13) 0.091
Deceased related to stroke 14 (11) 12 (9) 0.665
Deceased during one-year
follow-up
37 (28) 32 (24) 0.461
Deceased during two-year
follow-up
49 (37) 38 (29) 0.138
*Related to first stroke: death within 3 days. #Pearson’s Chi-square test.
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follow-up (p = 0.511) (Figure 1) or at two-year follow-up
(Figure 2) (p = 0.188).
Table 2 shows the percentage of patients that died in
both cohorts. In cohort 1 more men and women died than
in cohort 2; however, the difference is not significant. In
both cohorts more patients died with increasing age.Healthcare in general practice
For healthcare consumption of patients in general practice,
a distinction was made between the consults and visits
with the GP and/or nurse practitioner. There were no
significant differences between healthcare consumption of
the two cohorts with the exception of the average number
of contacts with the nurse practitioner (Table 3).Table 3 Healthcare provided by general practice during two-y
Variables
Median number of contacts with GP (consults/visits) per patient per year
Median number of consults per patient per year
Median number of home visits per patient per year
Median number of contacts with nurse practitioner per patients per year
# Mann–Whitney test.Secondary prevention
Theoretically, the LTA should lead to an increase in
the number of ICPC codes in cohort 2 compared to
cohort 1 (Table 4). Table 4 shows that all ICPC
codes are more frequently applied in cohort 2 than
in cohort 1; however, the difference is significant
only for hypercholesterolemia.
Medication
With the introduction of the new protocol more attention
is paid to secondary prevention and the prescription of
medication, e.g. aspirin and statins. Table 5 presents data
on the number of patients who were prescribed several
types of medication in the year preceding the stroke and
in the following two years post stroke.
The results show that in both cohorts significantly more
cholesterol-lowering medication and antithrombotics were
prescribed after stroke. Also, only in cohort 2 significantly
more medication affecting the renin-angiotensin system
was prescribed after stroke.
Discussion
This study examined whether the survival of stroke
patients changed after the introduction of the ‘Dutch
Transmural Protocol TIA/CVA’ , and whether the number
of contacts with the GP/nurse practitioner, registration
of comorbidity, and prescription rate of medication
increased.
The two cohorts were well matched regarding the
number of patients, age, gender and comorbidity.
After introduction of the LTA there was no significant
difference in survival between cohort 1 and 2. We
expected survival to improve after introduction of the
LTA because the GPs could use the FAST test, i.e. a
checklist in which patients are sent to hospital directly
after telephone contact without causing any delay [12,21].
An explanation for this result might simply be that the
LTA does not lead to improved survival, despite rapid and
effective patient care. Another possibility is that the situ-
ation envisaged with the LTA was not achieved, perhaps
due to problems associated with the implementation of
thrombolysis and stroke unit treatment [22,23].
Although survival is slightly better in cohort 2 (Figures 1
and 2), our results show that there was no significant
improvement in long-term survival after introduction ofear follow-up
Cohort 1 (range) Cohort 2 (range) p-value#
8.0 (0–44) 7.0 (0–36) 0.801
2.0 (0–31) 2.0 (0–30) 0.746
2.0 (0–33) 1.0 (0–30) 0.230
0.0 0.0 (0–17) <0.001
Table 4 Number (%) of patients with different risk factors
included in the prescription register and/or journal two
years after stroke
ICPC Cohort 1 (%) Cohort 2 (%) p-value*
K85 (high blood pressure
without hypertension)
3 (2.3) 8 (6.1) 0.127
K86/87 (hypertension) 54 (41.2) 63 (47.7) 0.288
T93 (hypercholesterolemia) 24 (18.3) 45 (34.1) 0.004
T90 (diabetes) 26 (19.8) 31 (23.5) 0.474
K91 (arteriosclerosis) 1 (0.8) 2 (1.5) 0.566
*Pearson’s Chi-square test.
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a significant difference as both curves tend to diverge
progressively over time.
The number of patient contacts in general practice
was expected to increase after introduction of the LTA,
because the LTA recommends GPs to aim for intensive
rehabilitation and to monitor secondary prevention in
stroke patients [12]. This should lead to an increase in
the number of GP contacts, especially in the first year
after stroke. There was a slight increase in contacts with
the nurse practitioner, a nurse practitioner assists the GP
in care for chronic patients [24], including stroke patients.
This might be explained by the recent introduction of
nurse practitioners for cardiovascular risk management in
GP offices. Although there was an increase in contacts
with the nurse practitioner this was not the case for the
number of GP contacts and visits. A possible explanation
is the establishment of GP centers, which probably means
that visits by the GP in the evenings/weekends are no
longer necessary [25]. Moreover, there is a tendency
towards more telephone contacts and fewer home visits
[26]. Another explanation is that insufficient attention
is paid to rehabilitation by GPs, implying the stricter
implementation of the LTA may still be beneficial. Expos-
ure time (defined as number of days during which patients
were registered in a general practice) was the same in
both groups.Table 5 Number of patients who were prescribed several typ
two years post stroke (After)
Medication Number of patien
Before After
Antithrombotics 50 (38.2) 85 (64
Diuretics 55 (33.6) 36 (27
Beta-receptor blocker 35 (26.7) 46 (35
Calcium channel blocker 14 (10.7) 21 (16
Medication influencing renin-angiotensin system 20 (15.3) 30 (22
Antidiabetics 20 (15.3) 19 (14
Cholesterol-lowering medication 15 (11.5) 23 (17
* Pearson’s Chi-square test.According to the LTA, secondary prevention in stroke
patients is important, especially for the GP [12]. This
should lead to an increase in the number of risk factors in
cohort 2 compared to cohort 1. The data indeed showed
an increase, but only the increase of hypercholesterolemia
is significant; this might be because (in 2003) treatment of
stroke patients (without elevated cholesterol) with statins
proved to be effective [12,27]. However, whether secondary
prevention has in fact improved remains debatable. A
future questionnaire study among GPs and patients
might provide more insight into secondary prevention
after implementation of the LTA.
Implementation of the LTA was expected to increase
use of medication to treat risk factors. The increase in
prescription rate of certain types of medication is not
per se due to the introduction of the LTA, but also
because of new insights into drug use. In both cohorts
almost all medication is prescribed more frequently after
stroke than before stroke. However, only for cholesterol-
lowering medication and antithrombotic medication is
this increase significant. The increase in use of statins is
probably because they are known to be effective in stroke
patients, regardless of cholesterol levels [27]. Furthermore,
significantly more ACE inhibitors are prescribed after
stroke in cohort 2; this might be because ACE inhibi-
tors are known to very effective in the treatment of
hypertension [28].
Overall, this study showed only minimal differences
between cohort 1 and 2. A possible reason for this is that
there were no major differences in the groups before
introduction of the LTA. Another explanation could be
that there was already a shift in the referral and treatment
patterns in stroke.
This study has several limitations. The study popula-
tion was selected from general practices in the northern
part of the Netherlands. To be more representative, the
study group should be selected from multiple general
practices throughout the Netherlands.
Furthermore, this registry study and its design were
not suitable to examine a causal relationship between thees of medicine from one year before stroke (Before) until
ts in Cohort 1 (%) Number of patients in Cohort 2 (%)
p-value* Before After p-value*
.9) <0.001 56 (42.4) 103 (78.0) <0.001
.5) 0.165 47 (35.6) 49 (37.1) 0.798
.1) 0.120 49 (37.1) 48 (36.4) 0.898
.0) 0.116 18 (13.6) 13 (9.8) 0.339
.9) 0.243 40 (30.3) 58 (43.9) 0.022
.5) 0.964 24 (18.2) 28 (21.2) 0.536
.6) 0.035 39 (29.5) 68 (51.5) <0.001
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secondary outcomes.
In 2003 in the Netherlands a new healthcare system was
introduced and (amongst other changes) required more
accurate registration of data. Cohort 1 was selected before
these changes and cohort 2 after these changes were intro-
duced. Therefore, some results may be due to improved
registration rather than to the influence of the LTA. How-
ever, in the present study this is accounted for by, for
example, not examining the number of prescriptions written
by the GP because this was hardly registered in cohort 1.
It should also be noted that registration in the RNG
depends on the personal preference of the GP. The ICPC
codes do not measure in absolute terms what they intend
to measure. A follow-up study should not only use the
dataset, but should also send questionnaires to the patients
so that all details from the medical records can be verified.
Conclusion
The ‘Dutch Transmural Protocol TIA/CVA’ was introduced
to improve survival after stroke and minimize the risk of
stroke recurrence. No major change in one-year survival
was found after introduction of the LTA. For the secondary
outcomes, a significant increase was found in the number
of patients diagnosed with of hypercholesterolemia and
in prescriptions of ACE inhibitors. Also, a slight increase
was observed in the number of contacts with the nurse
practitioner. However, these results may be due to the
introduction of the LTA and/or to other causes.
Practice implications
This study shows that, even after introduction of the
LTA, the ideal treatment has not yet been achieved.
Improvements might be made by more stringent follow-up
of the LTA in general practice. Future research should
focus on, e.g., using questionnaires to obtain more data on
implementation of the LTA by GPs, and to what extent it
is found to be effective. Also, a longer follow-up period
might reveal a significant difference in survival.
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